Global And China Opioids Drug Market Insights, Forecast To 2027

1 Study Coverage
1.1 Opioids Drug Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Drug Market Size Growth Rate by Type
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Market by Application
1.3.1 Global Opioids Drug Market Size Growth Rate by Application
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Opioids Drug Market Size, Estimates and Forecasts
2.1.1 Global Opioids Drug Revenue 2016-2027
2.1.2 Global Opioids Drug Sales 2016-2027
2.2 Global Opioids Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Opioids Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Opioids Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Opioids Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Opioids Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Opioids Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Opioids Drug Revenue Forecast by Region (2022-2027)

3 Global Opioids Drug Competitor Landscape by Players
3.1 Global Top Opioids Drug Manufacturers by Sales
3.1.1 Global Opioids Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Opioids Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Opioids Drug Manufacturers by Revenue
3.2.1 Key Opioids Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Opioids Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Opioids Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Opioids Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Opioids Drug Revenue in 2020
3.2.6 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Opioids Drug Price by Manufacturers
3.4 Global Opioids Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioids Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioids Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Opioids Drug Market Size by Type (2016-2021)
4.1.1 Global Opioids Drug Sales by Type (2016-2021)
4.1.2 Global Opioids Drug Revenue by Type (2016-2021)
4.1.3 Opioids Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Opioids Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Opioids Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Opioids Drug Revenue Forecast by Type (2022-2027)
4.2.3 Opioids Drug Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Opioids Drug Market Size by Application (2016-2021)
5.1.1 Global Opioids Drug Sales by Application (2016-2021)
5.1.2 Global Opioids Drug Revenue by Application (2016-2021)
5.1.3 Opioids Drug Price by Application (2016-2021)
5.2 Opioids Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Opioids Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Opioids Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioids Drug Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Opioids Drug Market Size YoY Growth 2016-2027
6.1.1 China Opioids Drug Sales YoY Growth 2016-2027
6.1.2 China Opioids Drug Revenue YoY Growth 2016-2027
6.1.3 China Opioids Drug Market Share in Global Market 2016-2027
6.2 China Opioids Drug Market Size by Players (International and Local Players)
6.2.1 China Top Opioids Drug Players by Sales (2016-2021)
6.2.2 China Top Opioids Drug Players by Revenue (2016-2021)
6.3 China Opioids Drug Historic Market Review by Type (2016-2021)
6.3.1 China Opioids Drug Sales Market Share by Type (2016-2021)
6.3.2 China Opioids Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Opioids Drug Price by Type (2016-2021)
6.4 China Opioids Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Opioids Drug Sales Forecast by Type (2022-2027)
6.4.2 China Opioids Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Opioids Drug Price Forecast by Type (2022-2027)
6.5 China Opioids Drug Historic Market Review by Application (2016-2021)
6.5.1 China Opioids Drug Sales Market Share by Application (2016-2021)
6.5.2 China Opioids Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Opioids Drug Price by Application (2016-2021)
6.6 China Opioids Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Opioids Drug Sales Forecast by Application (2022-2027)
6.6.2 China Opioids Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Opioids Drug Price Forecast by Application (2022-2027)

7 North America
7.1 North America Opioids Drug Market Size YoY Growth 2016-2027
7.2 North America Opioids Drug Market Facts & Figures by Country
7.2.1 North America Opioids Drug Sales by Country (2016-2021)
7.2.2 North America Opioids Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Opioids Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Opioids Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Opioids Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Opioids Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Opioids Drug Market Size YoY Growth 2016-2027
9.2 Europe Opioids Drug Market Facts & Figures by Country
9.2.1 Europe Opioids Drug Sales by Country (2016-2021)
9.2.2 Europe Opioids Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Opioids Drug Market Size YoY Growth 2016-2027
10.2 Latin America Opioids Drug Market Facts & Figures by Country
10.2.1 Latin America Opioids Drug Sales by Country (2016-2021)
10.2.2 Latin America Opioids Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Opioids Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Opioids Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Opioids Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Opioids Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Opioids Drug Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Corporation Information
12.2.2 Purdue Pharma Description and Business Overview
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Purdue Pharma Opioids Drug Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Description and Business Overview
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Opioids Drug Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Corporation Information
12.4.2 Amneal Pharma Description and Business Overview
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amneal Pharma Opioids Drug Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Corporation Information
12.5.2 Collegium Description and Business Overview
12.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Collegium Opioids Drug Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Corporation Information
12.6.2 J&J Description and Business Overview
12.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 J&J Opioids Drug Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Corporation Information
12.7.2 Endo Description and Business Overview
12.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Opioids Drug Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Opioids Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Corporation Information
12.9.2 INSYS Description and Business Overview
12.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 INSYS Opioids Drug Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Description and Business Overview
12.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mylan Opioids Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Opioids Drug Products Offered
12.11.5 Teva Recent Development
12.12 Egalet
12.12.1 Egalet Corporation Information
12.12.2 Egalet Description and Business Overview
12.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Egalet Products Offered
12.12.5 Egalet Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Opioids Drug Industry Trends
13.2 Opioids Drug Market Drivers
13.3 Opioids Drug Market Challenges
13.4 Opioids Drug Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioids Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Opioids Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Global Opioids Drug Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 7. Global Opioids Drug Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Opioids Drug Sales by Regions (2016-2021) & (M Units)
Table 9. Global Opioids Drug Sales Market Share by Regions (2016-2021)
Table 10. Global Opioids Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Opioids Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 12. Global Opioids Drug Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Opioids Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Opioids Drug Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Opioids Drug Sales by Manufacturers (2016-2021) (M Units)
Table 16. Global Opioids Drug Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Opioids Drug Manufacturers by Revenue (US$ Million) in 2020
Table 18. Opioids Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Opioids Drug Revenue Share by Manufacturers (2016-2021)
Table 20. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2020)
Table 22. Key Manufacturers Opioids Drug Price (2016-2021) (USD/Unit)
Table 23. Opioids Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Opioids Drug Product Type
Table 25. Date of International Manufacturers Enter into Opioids Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Opioids Drug Sales by Type (2016-2021) (M Units)
Table 28. Global Opioids Drug Sales Share by Type (2016-2021)
Table 29. Global Opioids Drug Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Opioids Drug Revenue Share by Type (2016-2021)
Table 31. Opioids Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Opioids Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 33. Global Opioids Drug Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Opioids Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Opioids Drug Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Opioids Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Opioids Drug Sales by Application (2016-2021) (M Units)
Table 38. Global Opioids Drug Sales Share by Application (2016-2021)
Table 39. Global Opioids Drug Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Opioids Drug Revenue Share by Application (2016-2021)
Table 41. Opioids Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Opioids Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 43. Global Opioids Drug Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Opioids Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Opioids Drug Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Opioids Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. China Opioids Drug Sales (M Units) of Key Companies (2016-2021)
Table 48. China Opioids Drug Sales Share by Company (2016-2021)
Table 49. China Opioids Drug Revenue (US$ Million) by Company (2016-2021)
Table 50. China Opioids Drug Revenue Share by Company (2016-2021)
Table 51. China Opioids Drug Sales (M Units) by Type (2016-2021)
Table 52. China Opioids Drug Sales Share by Type (2016-2021)
Table 53. China Opioids Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Opioids Drug Price (USD/Unit) by Type (2016-2021)
Table 55. China Opioids Drug Sales (M Units) by Type (2022-2027)
Table 56. China Opioids Drug Sales Share by Type (2022-2027)
Table 57. China Opioids Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Opioids Drug Revenue Share by Type (2022-2027)
Table 59. China Opioids Drug Price (USD/Unit) by Type (2022-2027)
Table 60. China Opioids Drug Sales (M Units) by Application (2016-2021)
Table 61. China Opioids Drug Sales Share by Application (2016-2021)
Table 62. China Opioids Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Opioids Drug Price (USD/Unit) by Application (2016-2021)
Table 64. China Opioids Drug Sales (M Units) by Application (2022-2027)
Table 65. China Opioids Drug Sales Share by Application (2022-2027)
Table 66. China Opioids Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Opioids Drug Revenue Share by Application (2022-2027)
Table 68. China Opioids Drug Price (USD/Unit) by Application (2022-2027)
Table 69. North America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 70. North America Opioids Drug Sales Market Share by Country (2016-2021)
Table 71. North America Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 74. Asia Pacific Opioids Drug Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Opioids Drug Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Opioids Drug Revenue Market Share by Region (2016-2021)
Table 77. Europe Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 78. Europe Opioids Drug Sales Market Share by Country (2016-2021)
Table 79. Europe Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Opioids Drug Revenue Market Share by Country (2016-2021)
Table 81. Latin America Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 82. Latin America Opioids Drug Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Opioids Drug Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 86. Middle East and Africa Opioids Drug Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Opioids Drug Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Opioids Drug Revenue Market Share by Country (2016-2021)
Table 89. Teva Corporation Information
Table 90. Teva Description and Business Overview
Table 91. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Teva Opioids Drug Product
Table 93. Teva Recent Development
Table 94. Purdue Pharma Corporation Information
Table 95. Purdue Pharma Description and Business Overview
Table 96. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Purdue Pharma Product
Table 98. Purdue Pharma Recent Development
Table 99. Mallinckrodt Corporation Information
Table 100. Mallinckrodt Description and Business Overview
Table 101. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. Mallinckrodt Product
Table 103. Mallinckrodt Recent Development
Table 104. Amneal Pharma Corporation Information
Table 105. Amneal Pharma Description and Business Overview
Table 106. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Amneal Pharma Product
Table 108. Amneal Pharma Recent Development
Table 109. Collegium Corporation Information
Table 110. Collegium Description and Business Overview
Table 111. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Collegium Product
Table 113. Collegium Recent Development
Table 114. J&J Corporation Information
Table 115. J&J Description and Business Overview
Table 116. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. J&J Product
Table 118. J&J Recent Development
Table 119. Endo Corporation Information
Table 120. Endo Description and Business Overview
Table 121. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Endo Product
Table 123. Endo Recent Development
Table 124. Pfizer Corporation Information
Table 125. Pfizer Description and Business Overview
Table 126. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Pfizer Product
Table 128. Pfizer Recent Development
Table 129. INSYS Corporation Information
Table 130. INSYS Description and Business Overview
Table 131. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. INSYS Product
Table 133. INSYS Recent Development
Table 134. Mylan Corporation Information
Table 135. Mylan Description and Business Overview
Table 136. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Mylan Product
Table 138. Mylan Recent Development
Table 139. Hikma Corporation Information
Table 140. Hikma Description and Business Overview
Table 141. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. Hikma Product
Table 143. Hikma Recent Development
Table 144. Egalet Corporation Information
Table 145. Egalet Description and Business Overview
Table 146. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Egalet Product
Table 148. Egalet Recent Development
Table 149. Opioids Drug Market Trends
Table 150. Opioids Drug Market Drivers
Table 151. Opioids Drug Market Challenges
Table 152. Opioids Drug Market Restraints
Table 153. Opioids Drug Customers List
Table 154. Opioids Drug Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Global Opioids Drug Sales Market Share by Application in 2020 & 2027
Figure 8. Pain Relief
Figure 9. Anesthesia
Figure 10. Others
Figure 11. Opioids Drug Report Years Considered
Figure 12. Global Opioids Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Opioids Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Opioids Drug Sales 2016-2027 (M Units)
Figure 15. Global Opioids Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Opioids Drug Sales Market Share by Region (2016-2021)
Figure 17. Global Opioids Drug Sales Market Share by Region in 2020
Figure 18. Global Opioids Drug Revenue Market Share by Region (2016-2021)
Figure 19. Global Opioids Drug Revenue Market Share by Region in 2020
Figure 20. Global Opioids Drug Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Opioids Drug Revenue in 2020
Figure 22. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Opioids Drug Sales Market Share by Type (2016-2021)
Figure 24. Global Opioids Drug Sales Market Share by Type in 2020
Figure 25. Global Opioids Drug Revenue Market Share by Type (2016-2021)
Figure 26. Global Opioids Drug Revenue Market Share by Type in 2020
Figure 27. Global Opioids Drug Sales Market Share by Application (2016-2021)
Figure 28. Global Opioids Drug Sales Market Share by Application in 2020
Figure 29. Global Opioids Drug Revenue Market Share by Application (2016-2021)
Figure 30. Global Opioids Drug Revenue Market Share by Application in 2020
Figure 31. China Opioids Drug Sales Growth Rate 2016-2027 (M Units)
Figure 32. China Opioids Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Opioids Drug Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Opioids Drug Players Market Share by Revenue in Opioids Drug in 2020
Figure 35. China Opioids Drug Revenue Share by Type (2016-2021)
Figure 36. China Opioids Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Opioids Drug Revenue Share by Application (2016-2021)
Figure 38. China Opioids Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Opioids Drug Sales Growth Rate 2016-2021 (M Units)
Figure 40. North America Opioids Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Opioids Drug Sales Market Share by Country in 2020
Figure 42. North America Opioids Drug Revenue Market Share by Country in 2020
Figure 43. U.S. Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 44. U.S. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 46. Canada Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Opioids Drug Sales Growth Rate 2016-2021 (M Units)
Figure 48. Europe Opioids Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Opioids Drug Sales Market Share by Country in 2020
Figure 50. Europe Opioids Drug Revenue Market Share by Country in 2020
Figure 51. Germany Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 52. Germany Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 54. France Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 56. U.K. Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 58. Italy Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 60. Russia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Opioids Drug Sales Growth Rate 2016-2021 (M Units)
Figure 62. Asia Pacific Opioids Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Opioids Drug Sales Market Share by Region in 2020
Figure 64. Asia Pacific Opioids Drug Revenue Market Share by Region in 2020
Figure 65. China Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 66. China Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 68. Japan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 70. South Korea Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 72. India Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 74. Australia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 76. China Taiwan Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 78. Indonesia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 80. Thailand Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 82. Malaysia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Opioids Drug Sales Growth Rate 2016-2021 (M Units)
Figure 84. Latin America Opioids Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Opioids Drug Sales Market Share by Country in 2020
Figure 86. Latin America Opioids Drug Revenue Market Share by Country in 2020
Figure 87. Mexico Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 88. Mexico Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 90. Brazil Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 92. Argentina Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Opioids Drug Sales Growth Rate 2016-2021 (M Units)
Figure 94. Middle East and Africa Opioids Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Opioids Drug Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Opioids Drug Revenue Market Share by Country in 2020
Figure 97. Turkey Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 98. Turkey Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 100. Saudi Arabia Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Opioids Drug Sales Growth Rate (2016-2021) (M Units)
Figure 102. UAE Opioids Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Opioids Drug Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.